vh2022
  • Home
    • About
    • 2022 Committee
    • Privacy Policy
    • Environmental Policy
  • Register
    • Registration Rates
    • Why register
    • Terms & Conditions
    • Accommodation
    • Venue & Location
    • COVID-19 Information
  • Program
    • 2022 Program
    • 2022 Poster Listing
    • Abstract Submission
    • Associated Events
  • Speakers
    • Keynote Speakers 2022
    • Speaker Presentation Assistance
  • Sponsorship
    • Sponsors
    • Why Sponsor
  • Scholarship Opportunities
  • Contact Us
  • Digital Toolkit
  • VH2021 Conference
  • Search
  • Menu Menu
  • Twitter
  • Facebook

vh2021

2021

LIVE PROGRAM

Join Our Mailing List

KEY DEADLINES



Abstract Submission Deadline: CLOSED


Early Bird Registration Deadline: CLOSED


Accommodation Deadline: CLOSED


Standard Registration Deadline: CLOSED

REGISTER

2021 Live Program

SundayMondayTuesday

8.00am

Registration Opens

9.10am – 11.00am

Opening Ceremony & Invited Speaker Session 01

9.10am – 9.15am

9.15am – 9.20am

9.20am – 9.25am

9.25am – 9.30am

9.30am – 9.50am

9.50am – 10.10am

10.10am – 10.30am

10.30am – 11.00am

11.00am – 11.05am

Welcome to Country

Speaker: Shannon Ruska

Committee Welcome

Speaker: Kevin Marriott, Hepatitis Australia, QLD

Community Welcome

Speaker: Thomas Tu, University Of Sydney and Westmead Institute for Medical Research, NSW

Government Welcome

Speaker: Hon Yvette D’Ath, Minister for Health and Ambulance Services, QLD

Using data linkage to better understand progress towards viral elimination targets

Speaker, Jennifer MacLachlan, The Doherty Institute, VIC

Stigma and discrimination

Speaker: Timothy Broady, Centre for Social Research in Health, UNSW, NSW

Mental Health

Speaker: Megan Hughes, Sexual Health Services Tasmania, TAS

Q&A

Hepatitis Australia Statement

Carrie Fowlie, Hepatitis Australia, ACT

11.00am – 11.30am

Morning Tea

11.30am – 1.00pm

Plenary 01

11.30am – 12.00pm

12.00pm – 12.30pm

12.30pm – 12.45pm

12.45pm – 1.00pm

Keynote Presentation 01: Taking stock of HBV elimination efforts: Where are we now and what are the challenges for the future?

Speaker: Yusuke Shimakawa, Senior epidemiologist, Emerging Disease Epidemiology Unit, Institut Pasteur, Paris, France

Keynote Presentation 02: Hepatitis B in the CALD Community

Speaker: Zihong Gu, Program Manager, HIV, Hepatitis and Sexual Health Program at the Ethnic Communities Council of Queensland, Brisbane, QLD

Outcomes of the CT2 Study: A ‘One-Stop-Shop’ for Community-Based, General Practitioner-Led Hepatitis C Point-of-Care Testing and Treatment in Yangon, Myanmar

Speaker: Bridget Draper, Burnet Institute, VIC

Hepatitis C micro-elimination in mental health settings using a nurse led model of care

Speaker: Kristen McKee, Storr Liver Centre, Westmead Hospital, NSW

1.00pm – 2:00pm

Lunch

1:15pm – 1:55pm

Hepatitis B s100 Case Discussion

Open to HBV s100 Prescribers only. To register please contact Jane Teiken: jane.tieken@ashm.org.au, M: 0411 536 307

2.00pm – 3.30pm

Proffered Paper Session 01

2.00pm – 2.15pm

2.15pm – 2.30pm

2.30pm – 2.45pm

2.45pm – 3.00pm

3.00pm – 3.05pm

3.05pm – 3.10pm

3.10pm – 3.15pm

3.15pm – 3.20pm

3.20pm – 3.25pm

3.25pm – 3.30pm

Uptake of Perinatal Immunoprophylaxis for Infants Born to Women with a Record of Hepatitis B in Victoria (2009 – 2017)

Speaker: Anna Deng, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, VIC

How do Mothers with Chronic Hepatitis B Understand and Experience the Prevention of Mother to Child Transmission Interventions in Victoria?

Speaker: Nafisa Yussf, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, VIC

Tasmanian eliminate hepatitis c Australian outreach project (TEHCAO)

Speaker: Megan Hughes, Sexual Health Services Tasmania, TAS

Interrupted Progress: Decline in Viral Hepatitis Testing and Care During Covid-19

Speaker: Jennifer MacLachlan, The Doherty Institute, VIC

Analysing the Effects of HBV Splice Variants on Wildtype HBV Replication

Speaker: Laura McCoullough, Victorian Infectious Diseases Reference Laboratory, VIC

An Updated Estimate of the Annual Number of New Hepatitis C Infections Among People Who Inject Drugs in Australia

Speaker: Anna Palmer, Burnet Institute, VIC

Data Linkage for Surveillance of Newly Acquired Hepatitis C Infections in Queensland: Early Findings and Implications for Policy and Practice

Speaker: Damin Si, Queensland Department Of Health, QLD

Just a GP, Just a Finger Prick, Just an Hour

Speaker: Joss O’loan, Kombi Clinic, QLD

Beyond the C: Hepatitis C Elimination in Your Practice

Speaker: Olivia Dawson, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, NSW

Palen Creek Prison Cures; HCV Elimination in a Weekend

Speaker: Joss O’loan & Mim O’Flynn, Kombi Clinic, QLD

3.30pm – 4.00pm

Afternoon Tea

4.00pm – 5.30pm

Invited Speaker Session 02

4.00pm – 4.20pm

4.20pm – 4.40pm

4.40pm – 5.00pm

5.00pm – 5.30pm

Addressing viral hepatitis in regional and remote settings

Speaker: Jane Davies, Menzies School of Health Research, NT

Engaging CALD communities with testing, monitoring and care for hepatitis B and C

Speaker: Jack Wallace, The Burnet Institute, VIC

Homelessness

Speaker: Mary-Anne Rushford, Bolton Clarke, VIC

Q&A

5.30pm – 6.15pm

Fit for purpose? HCV notification in the post DAA world

Chair: Linda Selvey, The University of Queensland

Panellists: Nik Alexander, Queensland Injectors Health Network (QuiHN), QLD, Greg Dore, The Kirby Institute, UNSW Sydney, Margaret Hellard, Burnet Insitute, VIC, Stephen Lambert, The University of Queensland, QLD

6.15pm – 6.45pm

Networking Drinks

7.30am

Registration Opens

8.30am – 11.15am

Invited Speaker Session 03

8.30am – 8.35am

8.35am – 8.40am

8.40am – 8.45am

8.45am – 9.05am

9.05am – 9.25am

9.25am – 9.45am

9.45am – 10.15am

10.15am – 10.45am

Welcome to Country

Speaker: Yvonne Weldon

Committee Welcome

Speaker: Mark Stoove, Burnet Institute

Community Welcome

Speaker: Pamela Wood, Hepatitis Australia, VIC

Leveraging learnings from Australian point-of-care testing networks to inform scale-up of hepatitis C RNA testing

Speaker: Susan Matthews, International Centre for Point of Care Testing, SA

Patient perspectives on testing methods

Speaker: Esha Leyden, Queensland Injectors Health Network, QLD

Linkage to care and sustainability of models

Speaker: Marianne Martinello, The Kirby Institute, UNSW, NSW

Q&A

Connecting with care

Moderator: Conor Ashleigh, Digital Storyteller

Panellists: Rhondda Lewis, Cairns Sexual Health Service, QLD, Darren Russell, Cairns Sexual Health Service, QLD, Kathy Clark, Cairns Hepatitis Action Team, QLD

10.45am – 11.15am

Morning Tea

11.15am – 1.00pm

Plenary 02

11.15am – 11.45pm

11.45am – 12.15pm

12.15pm – 12.30pm

12.30pm – 12.45pm

12.45pm – 1.00pm

Keynote Presentation 03: Taking stock of HCV elimination efforts: Where are we now and what are the challenges for the future?

Speaker: Natasha Martin, University of California San Diego, USA

Keynote Presentation 04: Community perspective: how are we are actually engaging people in treatment and management for viral hepatitis

Speaker: Chris Gough, Executive Director of the Canberra Alliance for Harm Minimisation and Advocacy (CAHMA) and The Connection health service, Canberra, ACT

Reduced Hepatitis C Incidence Associated with Rapid Treatment Scale-Up in Australian Prisons: Treatment-as-Prevention in the Stop-C Study

Speaker: Behzad Hajarizadeh, The Kirby Institute, UNSW Sydney, NSW

The C-LINK trial: a prospective randomised controlled trial showing that care-navigation post release from prisons increases linkage to hepatitis C care

Speaker: Alex Thompson, St Vincent’s Hospital Melbourne, VIC

The Levinia Crooks Emerging Leader Award Presentation

1.00pm – 2.00pm

Lunch

1.15pm – 2.00pm

Cepheid Sponsored Symposium

1.15pm – 1.35pm

1.35pm – 1.55pm

Implementing Point of Care HCV Viral Load Fingerstick in a prison setting

Speaker: Marian Bloomfield, Justice Health, NSW

Van (Liver)Life, taking Point of Care testing on the road

Speaker: Kristen McKee, Storr Liver Centre Westmead, NSW

2.00pm – 3.30pm

Proffered Paper Session 02

2.00pm – 2.15pm

2.15pm – 2.30pm

2.30pm – 2.45pm

2.45pm – 3.00pm

3.00pm – 3.05pm

3.05pm – 3.10pm

3.10pm – 3.15pm

3.15pm – 3.20pm

3.20pm – 3.25pm

3.25pm – 3.30pm

Interventions to Enhance Testing and Treatment Uptake for Hepatitis C Infection: A Systematic Review and Meta-Analysis

Speaker: Evan Cunningham, The Kirby Institute, UNSW Sydney, NSW

Hepatitis C Testing and Gaining Informed Consent: Taking Stock and Innovating for the Future

Speaker: Emily Lenton, Australian Research in Sex, Health and Society, VIC

Rapid point of care HCV testing allows high throughput HCV screening and rapid treatment uptake among PWID attending a medically supervised injecting room

Speaker: Michael Macisaac, St Vincent’s Hospital Melbourne, VIC

Point-of-care HCV RNA testing, linkage to nursing care, and peer-supported engagement and delivery to enhance HCV treatment among people with recent injecting drug use at a community-led needle and syringe program: the TEMPO pilot study

Speaker: Jason Grebely, The Kirby Institute, UNSW Sydney, NSW

Sentinel Surveillance of Hepatitis Cc Antibody Testing, Victoria, Australia, 2009 to 2019

Speaker: Anna Wilkinson, Burnet Institute, VIC

Exploring the Potential use of Notification Data to Increase Hepatitis C Treatment Uptake

Speaker: Shelley Walker, Burnet Institute, VIC

Slipping Through the Cracks? The Efficacy of Opt-Out HCV Testing in a Primary Health Care Facility Serving Marginalised Populations

Speaker: Vincent Cornelisse, Kirketon Road Centre, NSW

Prison Transition Program, a Community-Based Program; that Facilitates the Continuity of Care for Clients in Different Phases of HCV Treatment Among People Transitioning in or Out of Correctional Centre in South East

Speaker: Dorrit Grimstrup, QuIHN, QLD

Evaluation of the ‘Peers Assisting Treatment of Hepatitis C’ (PATH) Model in a Primary Care Setting in Melbourne, Australia

Speaker: Imogen Elsum, Burnet Institute, VIC & Carolyn Weidner, Harm Reduction Victoria, Melbourne, VIC

Jurisdictional Disparities in Progress Towards Improving the Cascade of Care for Chronic Hepatitis B in Australia

Speaker: Karen McCulloch, WHO Collaborating Centre For Viral Hepatitis, Doherty Institute, VIC

3.30pm – 4.00pm

Afternoon Tea

4.00pm – 5.30pm

Invited Speaker Session 04

4.00pm – 4.20pm

4.20pm – 4.40pm

4.40pm – 5.00pm

5.00pm – 5.30pm

Nursing and viral hepatitis care

Speaker: Sinead Sheils, Royal Prince Alfred Hospital Gastroenterology & Liver, NSW

Where are we on the Road to HBV Elimination and Cure?

Speaker: Peter Revill, The Doherty Institute, VIC

Adapting to COVID-19

Speaker: Phill Read, Kirketon Road Centre, NSW

Q&A

5.35pm – 6.05pm

Networking Drinks

8.30am

Registration Opens

9.00am – 10.45am

Invited Speaker Session 05

9.00am – 9.10am

9.10am – 9.30am

9.30am – 9.50am

9.50am – 10.10am

10.10am – 10.40am

10.40am – 10.45am

Tribute to Jude Byrne

Speaker: Annie Madden, Centre for Social Research in Health, UNSW Sydney, NSW

How much will it cost to eliminate viral hepatitis?

Speaker: Nick Scott, Burnet Institute, VIC

Prisons

Speaker: Colette McGrath, Justice Health, NSW

Government and policy maker role in elimination

Speaker: Stuart Manoj-Margison, Australian Government Department of Health, ACT

Q&A

Hepatitis Australia Statement

Speaker: Carrie Fowlie, Hepatitis Australia, ACT

10.45am – 11.15am

Morning Tea

11.15am – 12.45pm

Plenary 03

11.15am – 11.45am

11.45am – 12.15pm

12.15pm – 12.30pm

12.30pm – 12.45pm

Keynote Presentation 05: Success and challenges in addressing viral hepatitis in the Asia-Pacific

Speaker: Saeed Sadiq Hamid, Professor, Department of Medicine and Director of the Clinical Trials Unit, The Aga Khan University, Karachi, Pakistan

Keynote Presentation 06: Progress and future challenges for enhancing viral hepatitis care in Aboriginal and Torres Strait Islander people

Speaker: Dawn Casey, National Aboriginal Community Controlled Health Organisation, ACT

Development, Delivery and Evaluation of a Culturally Safe Hepatitis B Management Education Course for the Aboriginal Workforce to Increase Access and Reduce Health Inequity

Speakers: Amanda Dhagapan, Emily Vintour-Cesar, Phillip Wilson, Kelly Hosking, Teresa De Santis & Terese Ngurruwuthun, Menzies School of Health Research, NT

Hepatitis C Imaginaries: Findings from a New Study on Stigma, Discrimination and Post-Cure Lives

Speaker: Kate Seear, La Trobe University, VIC

12.45pm – 1.45pm

Lunch

1.45pm – 2.45pm

Proffered Paper Session 03

1.45pm – 2.00pm

2.00pm – 2.15pm

2.15pm – 2.30pm

2.30pm – 2.45pm

2.45pm – 2.50pm

2.50pm – 2.55pm

2.55pm – 3.00pm

3.00pm – 3.05pm

3.05pm – 3.10pm

3.10pm – 3.15pm

Identifying Enablers that Facilitate Hepatitis B Clinical Management in Primary Care Settings

Speaker: Jack Wallace, Burnet Institute, VIC

Quantifying Nurses Contribution to HCV Care Milestones: Findings from an Integrated Primary Healthcare Setting for Marginalised People

Speaker: Rosie Gilliver, Kirketon Road Centre, NSW

“We’ve had a Circuit Breaker for an Old Dogma of More Than 20 Years”: Changes to Opioid Agonist Treatment Services During COVID-19, the CHOICE Study

Speaker: Anna Conway, The Kirby Institute, UNSW Sydney, NSW

A Hidden Population: Supporting Healthy Ageing for People Who Inject Drugs

Speaker: Harini Walthati, AIVL, ACT

A Qualitative Exploration of Enablers to Hepatitis B Clinical Management Among Ethnic Chinese in Australia

Speaker: Yinzong Xiao, Burnet Institute, VIC

Find the Hero Inside You: World Hepatitis Day Digital Campaign

Speaker: Samantha White, Hepatitis Queensland, QLD

A Costing Analysis of a State-Wide, Nurse-Led Hepatitis C Treatment Model in Prison

Speaker: Anna Palmer, Burnet Institute, VIC

A Culturally Appropriate Evaluation of the “Hep B Story” App in a Remote Australian Community in Arnhem Land

Speaker: Paula Binks & George Gurruwiwi, Menzies School Of Health Research, NT

Violence and Hepatitis C Transmission in Prison – A Modified Social Ecological Model

Speaker: Hossain Sazzad, The Kirby Institute, UNSW Sydney, NSW

Reinfection in the Reach-C Cohort: Occurrence and Effectiveness of Retreatment for Hepatitis C Virus Reinfection Following Direct Acting Antiviral Therapy

Speaker: Joanne Carson, UNSW, NSW

3.15pm – 3.45pm

Afternoon Tea

3.45pm – 4.45pm

Closing Plenary

3.45pm – 4.30pm

4.30pm – 4.40pm

4.40pm – 4.45pm

Next steps in viral hepatitis responses: Perspectives from people with lived experience in honour of Jude Byrne

Facilitators: Annie Madden, Centre for Social Research in Health, UNSW, NSW & Carla Treloar, Centre for Social Research in Health, UNSW, NSW
Panellists: Thomas Tu, University of Sydney and Westmead Institute for Medical Research, NSW; Nafisa Yussf, WHO Collaborating Centre for Viral Hepatitis, VIC; Lien Tran,WHO Collaborating Centre for Viral Hepatitis, VIC; Jack Wallace, Burnet Institute, VIC; Chris Gough, CAHMA and the Connection, ACT

Committee closing remarks

Speaker: Jason Grebely, The Kirby Institute, UNSW Sydney, NSW

ASHM closing remarks

Speaker: Alexis Apostolellis, Chief Executive Officer, The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, NSW

We acknowledge that ASHM offices are located on the land of the Gadigal peoples of the Eora Nation (Sydney Office) and the Turrbal and Jagera/Yuggera peoples (Brisbane Office) who are the Traditional Owners of the lands where both offices are situated. We pay our respects to Elders past and present.


Copyright 2020 by ASHM Conference & Events Division
Scroll to top